Proper function of the Rev regulatory system is essential for the replication of lentiviruses, including feline immunodeficiency virus (FIV) and human immunodeficiency virus type 1 (HIV-1). Specifically, Rev affects the overall stability of viral mRNAs that encode necessary structural and enzymatic proteins. In turn, the eukaryotic initiation factor (eIF-5A) is indispensable for Rev function and is the only known protein whose biologically active form requires the unique amino acid, hypusine. Because 1,8-diaminooctane blocks the formation of hypusine by disrupting the cellular enzyme, deoxyhypusine synthase, thereby preventing activation of eIF-5A, we investigated the effects of 1,8-diaminooctane on posttranscriptional regulation. These are the first results to demonstrate that diaminooctane significantly reduced viral replication in a dose-dependent manner, even under conditions of contact inhibition, diminishing the compound's effect on cell proliferation. Similarly, the addition of increased concentrations of diaminooctane caused a reduction in the expression of a Rev-dependent CAT system without affecting a Rev-independent CAT system. At the RNA level, exposure of chronically infected CrFK cells to increasing concentrations of diaminooctane substantially decreased the levels of unspliced and singly spliced viral mRNAs and increased the relative amounts of multiply spliced transcripts in the cytoplasm. The findings of this study are the first demonstration that FIV, similar to HIV-1, requires eIF-5A for efficient Rev function and that small molecule intervention can indirectly target this lentivirus regulatory system.
INTRODUCTION
The essential role of virus production and viral burden in lentiviral pathogenesis has been well established (Coffin, 1995; Ho et al., 1995; Wei et al., 1995) . In feline immunodeficiency virus (FIV), as well as in human immunodeficiency virus (HIV), the role of cellular enzymes on viral replication need to be investigated more fully. One of these enzymes, deoxyhypusine synthase, has been targeted for its role in the synthesis of a unique amino acid, hypusine, required for generating the biologically active form of eukaryotic initiation factor 5A (eIF-5A) (Joe and Park, 1994; Joe et al., 1997; Park et al., 1993 Park et al., , 1998 Smit et al., 1989) . Active eIF-5A has been implicated in the function of the HIV-1 Rev transactivator protein (Bevec and Hauber, 1997; Bevec et al., 1996; Liu et al., 1997; Ruhl et al., 1993; Schatz et al., 1998; Steinkasserer et al., 1995) , which is required for lentivirus replication. Thus, compounds that target deoxyhypusine synthase may inhibit efficient production of virus.
A family of compounds, with diamine and triamine analogs, have been shown to act as inhibitors of deoxyhypusine synthase (Jakus et al., 1993; Park et al., 1994) .
Many of these compounds, including 1,8-diaminooctane, prevent eIF-5A from maturing into its active form (containing hypusine). Deoxyhypusine synthase is the enzyme which catalyzes the initial step in the posttranslational formation of the unique amino acid hypusine [N e -(4-amino-2-hydroxybutyl)lysine], found only in eIF-5A. Deoxyhypusine synthase mediates the NAD-dependent transfer of the butylamine moiety of the polyamine spermidine to the ⑀-amino group of the lys-50 residue in the eIF-5A precursor protein to form the deoxyhypusine residue. Hydroxylation of the deoxyhypusine residue by a specific hydroxylase completes hypusine synthesis and the maturation of eIF-5A Tao and Chen, 1995; Tao et al., 1994; Wolff et al., 1995) .
Targeting cellular enzymes required for viral replication may be effective in lowering viral burden while maintaining cellular integrity. Sequences encoding the major structural proteins (Gag, Pol, and Env) of lentiviruses are contained within potential introns. Without a sufficient quantity of Rev, these transcripts are spliced, removing the introns that encode the structural proteins, before reaching the cytoplasm for translation (Pollard and Malim, 1998) . Consequently, replication of the virus is dependent upon the Rev transactivating protein, whose function is to allow transport of specific viral RNAs from the nucleus to the cytoplasm. Rev is translocated into the nuclei of infected cells where it specifically binds as a monomer to unspliced or singly spliced transcripts that encode viral regulatory and structural proteins (Malim et al., 1988 crete cis-acting sequence, the Rev responsive element (RRE) (Daly et al., 1989; Malim et al., 1990) . Once Rev has interacted with its RRE, multimeric Rev complexes form, arising from Rev protein-protein interactions and the occupation of secondary RNA-binding sites (Pollard and Malim, 1998) . The formation of stable dimers appears to be needed for interaction with eIF-5A. eIF-5A appears to act as a specific adapter or bridging factor for binding of ribonuclear protein complex to export receptor CRM1/ exportin 1, by which the complex is transported through the nuclear pore in the presence of RanGTP (Bevec and Hauber, 1997; Schatz et al., 1998 ; for review see Hauber, 2001) . Through this pathway viral mRNAs are released into the cytoplasm before splicing is completed, allowing the translation of virion structural proteins.
It was reasoned that since 1,8-diaminooctane inhibits the enzyme deoxyhypusine synthase and prevents hypusine formation, it should also impede eIF-5A maturation and diminish FIV Rev function. With a predominance of inactivated eIF-5A, the Rev regulatory system would fail to transport intact (unspliced and singly spliced) viral mRNAs from the nucleus to the cytoplasm for translation. With Rev function diminished, viral structural protein translation should be limited, subsequently reducing viral replication. Here we report that this cascade specifically affects the Rev regulatory system and its ability to function properly. We have demonstrated that, through the inhibition of deoxyhypusine synthase (with 1,8-diaminooctane), we can effectively reduce FIV production in vitro without a reduction in cell proliferation. Also, we were able to reduce the expression of a Rev-dependent CAT reporter system without reducing expression of a Rev-independent CAT system. At the RNA level, viral mRNA splicing patterns in the cytoplasm of infected cells were altered.
RESULTS
The affect of 1,8-diaminooctane on viral replication and cell proliferation To determine whether diaminooctane could reduce virus production without affecting cell proliferation, both functions were assessed simultaneously. Increasing concentrations of diaminooctane were added to samples containing differentially seeded, chronically infected CrFK cells. The resulting data sets were divided by cell density in 6-and 12-well plates. In the subconfluent samples, both the cell proliferation and the viral replication (RT activity) decreased after the addition of diaminooctane (Fig. 1A) . However, in confluent cultures, diaminooctane had no effect on cell proliferation but caused a statistically significant reduction in FIV replication (Fig.  1B) . Trypan blue staining for the control and diaminooctane-treated cultures ranged from 95 to 98% viable cells, with the variability being diaminooctane concentration independent.
Rev function is inhibited by 1,8-diaminooctane
To determine if the decreased FIV replication related specifically to Rev function, we used a previously described FIV Rev-dependent CAT expression system (Phillips et al., 1992) . The results indicated that increasing amounts of diaminooctane incrementally reduced the expression of CAT, demonstrating that the Rev regulatory complex failed to function properly ( Fig. 2A) . Conversely, the FIV Rev-independent CAT expression system, pCAT (Promega), was not affected by the addition of diaminooctane. The data are represented in units of density as determined from exposure to autoradiographic film with converted product (acetylation) versus the concentration of diaminooctane that was added.
Analysis of splicing events
To determine if increasing amounts of 1,8-diaminooctane altered mRNA species, Northern blot analysis was performed. Cytoplasmic RNA from the CrFK cells were probed with random primer-labeled cDNA of full-length Rev, which is present in all known FIV mRNAs (Phillips et al., 1992) . Clearly, when the higher concentrations of diaminooctane were introduced and maintained in the cells' media, the amount of unspliced message decreased and the level of multiply spliced messages increased (Fig. 3A) . That is, the bands representing unspliced messages diminished as concentrations of diaminooctane exceeded 50 M, with a dramatic decrease in unspliced messages in samples containing 150 and 200 M; concomitantly, bands for the small, multiply spliced messages increased.
DISCUSSION
This study is the first to demonstrate that a small molecule, 1,8-diaminooctane (a diamine compound), can indirectly disrupt FIV Rev function. Based on information previously published, it is likely that diaminooctane, through its interaction with deoxyhypusine synthase, inhibits the conversion of a specific lysine residue in eIF-5A to the unique amino acid, hypusine Wolff et al., 1995) . This conversion is necessary for the formation of active eIF-5A, which in turn is required for proper Rev function. Therefore, it is likely that the effects of diaminooctane on the Rev regulatory system, although pronounced, were indirect Ruhl et al., 1993; Schatz et al., 1998) .
As Fig. 1A illustrates, the application of diaminooctane decreased both cell proliferation and virus replication in a dose-dependent manner. Since the rate of cell proliferation can affect virus replication, it was important to demonstrate that diaminooctane specifically lowered viral replication under conditions in which cell proliferation was not affected. Therefore, contact inhibition was used to limit cell proliferation. Under these conditions, diaminooctane significantly reduced viral replication in a con- centration-dependent manner without substantially altering cell proliferation (Fig. 1B) .
Active eIF-5A is necessary for both cell proliferation (Canellakis et al., 1989; Hanauske-Abel et al., 1994a; Lee and Folk, 1998; Liao et al., 1998; Park et al., 1997) and lentivirus replication (Liu et al., 1997; Schatz et al., 1998) . When increasing amounts of 1,8-diaminooctane were added to subconfluent cultures, both cell proliferation and viral replication decreased. In the absence of contact inhibition, proliferation is susceptible to the diamine treatment because of the cell's requirement for biologically active eIF-5A for division (Fig. 1A) (Hanauske-Abel et al., 1994b; Park et al., 1997) . Once the cells have reached confluence (i.e., nondividing due to contact inhibition), the antiproliferative effects of the diamine were minimal, as demonstrated by the nearly equivalent [
3 H]thymidine incorporation between the control and the diaminooctane samples (Fig. 1B) . Nondividing cells require less of the active form of eIF-5A (Torrelio et al., 1984) . However, for infected cells to produce new virus, the active form of eIF-5A is continually required (Junker et al., 1996; Liu et al., 1997; Schatz et al., 1998; Steinkasserer et al., 1995) . As the inactive form replaced a greater percentage of the active form, the FIV Rev regulatory system became increasingly unable to function properly, and the viral messages became more susceptible to multiple splicing. Thus, under conditions of contact inhibition (Fig. 1B) , diaminooctane had minimal antiproliferative effects, while retaining its ability to disrupt viral replication. The CAT reporter assay, performed under conditions of contact inhibition, demonstrated a selective effect of diaminooctane on the Rev regulatory system. In a concentration-dependent manner, Rev-dependent CAT expression ( Fig. 2A) was significantly reduced. Conversely, in the Rev-independent CAT expression (pCAT) (Fig. 2B) , diaminooctane demonstrated no significant effect. These results indicate that diaminooctane selectively modified the FIV Rev system.
To further confirm the effects of diaminooctane on the Rev regulatory system, the relative size of viral RNA in the cytoplasm was examined. When Rev was present and functioning correctly, large (unspliced) messages were found within the cytoplasm of FIV-infected cells. However, in the absence of Rev or a properly functioning Rev system, the smaller (multiple spliced) messages predominated. The Northern blot analysis in Fig. 3 demonstrated a greater susceptibility of viral messages to splicing under the pressure of diaminooctane. There was an inverse relationship between the amount of diaminooctane added to the cell cultures and the amount of intact message in the cytoplasm, indicating that diaminooctane was specifically affecting Rev function.
In a recent study, two ␣-hydroxypyridones, mimosine and deferiprone, were used to inhibit deoxyhypusyl hydroxylase and prevent the formation of active eIF-5A (Andrus et al., 1998) . The results demonstrated that the inhibition of deoxyhypusyl hydroxylase suppressed the replication of HIV-1 by decreasing the quantity of Revdependent mRNA and the structural protein p24. Although the study of Andrus et al. used different inhibitors that target deoxyhypusyl hydroxylase instead of deoxyhypusine synthase, and was conducted in an HIV-1 vs a FIV system, the results of the present study are in agreement that prevention of the formation of active eIF-5A inhibits lentivirus replication.
Biologically active eIF-5A is required for the Rev protein to function properly (Bevec and Hauber, 1997; Bevec et al., 1994 Bevec et al., , 1996 Junker et al., 1996; Katahira et al., 1995; Liu et al., 1997; Ruhl et al., 1993; Steinkasserer et al., 1995) . Bevec and colleagues have shown a direct link between eIF-5A and HIV-1 Rev (Bevec and Hauber, 1997; Ruhl et al., 1993) . The results of this study are the first to Shows the effect of diaminooctane on the Revindependent reporter system, pCAT/CMV. Note that the addition of diaminooctane decreased CAT expression in a concentration-dependent manner in the Rev-dependent CAT expression system, but did not effect the Rev-independent system. Statistical significance is indicated by asterisks: *P Յ 0.050. suggest a similar mechanism likely exists in the FIV Rev system and indicate the validity of the FIV/cat model.
Binding of the Rev protein to the RRE is not inhibited by inactive eIF-5A (Liu et al., 1997) . The bound Rev complex, in the absence of active eIF-5A, is unable to transport viral mRNA out of the nucleus and into the cytoplasm without being multiply spliced (Liu et al., 1997; Ruhl et al., 1993) . It appears that eIF-5A facilitates the binding of the Rev/RRE complex to the CRM1/exporter 1 system, which in turn transports the ribonuclear protein through the nuclear pore complex (Bogerd et al., 1998; Hauber, 2001) . eIF-5A is associated with the nuclear-pore-attached filaments, which radiate from the pore's opening into the nucleoplasm (Hauber, 2001) . It is believed that through these filaments the initial docking of the export cargo occurs. Thus, eIF-5A may play a role in facilitating the transport of export substrates to the nuclear pore for CRM1/exporter 1 mediated export through the pore channel. This whole process is dependent upon the presence of active eIF-5A (containing the hypusine modification). For a complete review, see Hauber (2001) . Diaminooctane, through its action on deoxyhypusine synthase, likely prevented the conversion of lysine to hypusine and thereby prevented the formation of active eIF-5A Wolff et al., 1995) , which in turn altered the efficient transportation of intron containing viral mRNA through the nuclear pore.
The highly conserved eIF-5A protein and its unique amino acid, hypusine (Gordon et al., 1987; Park et al., 1984) , provide an interesting and informative system to study the mechanisms involved with lentiviral replication. The continued investigation of this lentivirus regulatory system, utilizing indirect interactions mediated by linker proteins, may enhance understanding of the role cofactors play in viral transcript processing.
MATERIALS AND METHODS

Cell lines and viruses
For these studies, we used the Crandell feline kidney cells (CrFK) chronically infected with 34TF10 (Phillips et al., 1990 Talbott et al., 1989 ), a previously described infectious molecular clone of FIV. FIV-34TF10 was established from a tissue culture adapted strain of the Petaluma isolate of FIV (Pedersen et al., 1987) . CrFK cells were maintained in Dulbecco's modification of minimal essential medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 2 mM glutamine, sodium pyruvate (0.11 mg/ml), and gentamicin sulfate (50 g/ml). A viral stock of FIV-34TF10 was prepared by introducing 10 g of viral DNA into CrFK cells by electroporation (Talbott et al., 1989) . Viral replication was monitored by reverse transcriptase (RT) assay, as previously described (Phillips et al., 1990) .
Cellular treatment
CrFK cells were seeded in 6-or 12-well plates (Corning) at two initial concentrations: subconfluent (50,000) and confluent (100,000) cells/well. 1,8-Diaminooctane (Sigma) was dissolved in growth media, added to the cells, and maintained at concentrations of 50, 100, 150, and 200 M. The cellular supernatants were harvested every 48 h and replaced with fresh media containing the drug. 
CAT assay
Transient cotransfections were carried out in 6-and 12-well plates using a Rev expression plasmid (pFRev) and a Rev-dependent CAT expression plasmid (pFRRE). The Rev-dependent plasmid was made by the addition of FIV sequences that contained RRE to the 3Ј end of the CAT encoding mRNA, as previously described (Mancuso et al., 1994) . A Rev-independent CAT expression plasmid (pCAT) (Promega) was used as a control. A lipofectinbased transfection protocol DOTAP (Boehringer Mannheim) was used with 10 g of plasmid DNA for each sample. OptiMEM (Life Technologies) was the media used during the transfections in 1-ml volumes and then was removed after a 6-h incubation with the DOTAP. Cells were harvested following a 48-h incubation in normal DMEM with 10% FBS. The cells were harvested with a cell scraper, placed into ice-cold PBS, and then resuspended in 0.25 M Tris pH 7.5. The cells were disrupted with two freeze/thaw cycles in dry ice/EtOH bath and 37°C water bath. The cellular lysates were incubated at 37°C for 1 h with 14 C-chloramphenicol (Amersham CUA435) as the reporter and butyryl-CoA as the substrate. Samples were run on TLC plates (Baker) and exposed to Bio-Max (Kodak) single-sided emulsion film for clarity and densities were measured using the Investigator Series Video Capture Device (Fotodyne). The data were then compiled and processed using the NIH/Scion 1.61 software and are represented as density units.
Proliferation assay
Chronically infected CrFK cells were seeded at subconfluent (50,000 cells) and confluent (100,000 cells) levels in 6-or 12-well plates (as indicated). 1,8-Diaminooctane was added at 50, 100, and 200 M concentrations. Cells were maintained in media refreshed every 24 h. [ 3 H]Thymidine was added on the third day and incubated for 8 h, and cell-incorporated radioactivity was measured by liquid scintillation counting. Data were expressed as mean counts per minute per microgram of protein from quadruplicate samples.
Reverse transcriptase assay
Media harvested from cells used in the proliferation assay on the third day were used in a RT assay to determine the level of viral replication. Cells were seeded as stated above, and the supernatant was harvested and centrifuged at 230,000 g for 45 min at 22°C. The tubes were drained and swabbed to remove any residual medium and the pellets were air dried. The viral pellets were then resuspended thoroughly in 100 l of reaction mix (20 mM DTT, 40 mM Tris, 360 mM NaCl, 2% NP-40). The samples were freeze-thawed three times in a dry-ice/EtOH bath to disrupt virions, and then 25 l was mixed with an equal volume of buffer containing 40 mM Tris-HCl, pH 8.1, 60 mM NaCl, 0.02 U poly [rA(dT)] (Pharmacia-Biotech), 0.625 Ci [ 3 H]dTTP (80 Ci/mmol, NEN), and either 160 mM MgCl 2 or 1.2 mM MnCl 2 (negative control). After incubation for 1.5 h at 37°C, the samples (in quadruplicate) were spotted on Whattman DE81 filters and washed for 5 min each in 0.1 M sodium pyrophosphate and then in 0.3 M ammonium formate. After a final wash with 95% ethanol, the filters were dried under a heat lamp and counted by liquid scintillation. Data were expressed as counts per minute.
Northern blot
RNA was isolated from chronically infected CrFK cells using the Trizol LS (Life Technologies) method, following the manufacturer's protocol. Briefly, after cells were grown in media containing 0, 50, 100, 150, and 200 M of 1,8-diaminooctane for 3 days, supernatants were harvested for RT activity and the cells were harvested for cytoplasmic RNA isolation. Intact cells were resuspended in ice-cold lysis solution (50 mM Tris-Cl pH 8.0, 100 mM NaCl, 5 mM MgCl 2 , 0.5% v/v NP-40) to separate the cytoplasmic RNA from the nuclei. Nuclei were pelleted and Trizol LS solution was added to the supernatants for the isolation of cytoplasmic RNA. Separation into aqueous/organic phases was followed by precipitation of the RNA (aqueous phase) with isopropanol. The RNA was resuspended in diethylpyrocarbonate (DEPC)-treated water, and denaturing buffer (50% formamide, 2.2 M formaldehyde, and 1ϫ MOPS buffer) was added. The samples were incubated at 55°C for 15 min to disrupt secondary structure and then were loaded onto an agarose/formaldehyde denaturing gel (1% w/v agarose, 2.2 M formaldehyde, 1ϫ MOPS) in loading buffer (0.25% bromphenol blue, 0.25% xylene cyanol, 50% glycerol). Gels were run at 5 V/cm for approximately 3 h and rinsed to remove formaldehyde, and the RNA was blotted onto Hybond-N (Amersham Life Science) membranes. After overnight blotting, the membranes were crosslinked using the UV Stratalinker (Stratagene) and prehybridized for 30 min. Hybridization was accomplished using a rediprime (Amersham Life Science) random-primed [ 33 P]dCTP-labeled Rev cDNA probe in Rapid-hyb (Amersham Life Science) buffer for a total of 2 h. Total RNA was labeled for control. Blots were then rinsed, dried, and exposed to Bio-Max (Kodak) film overnight.
